Bionpharma
Private Company
Total funding raised: $20M
Overview
Bionpharma is a private, commercial-stage generic and specialty pharmaceutical company headquartered in Princeton, New Jersey. It operates a hybrid business model combining B2B activities—including generic drug development, manufacturing (notably softgel capsules), and contract services—with a direct-to-consumer e-commerce arm via its A+ Health brand on Amazon. The company's strategy is centered on providing cost-effective healthcare solutions through internal R&D and manufacturing, supported by overseas affiliates, and it is actively seeking in-licensing opportunities for the US market.
Technology Platform
Integrated generic & OTC pharmaceutical development and manufacturing platform, with specialization in softgel capsules and direct-to-consumer e-commerce via Amazon.
Funding History
1FDA Approved Drugs
1Opportunities
Risk Factors
Competitive Landscape
Bionpharma competes in the highly competitive generic pharmaceutical industry against large players like Teva, Sandoz (Novartis), and Mylan (Viatris), as well as numerous smaller generic firms. Its A+ Health brand competes with both established OTC brands and other digital-native healthcare brands on Amazon.